Investigational New Drug

Pic:getty/stockcolors

AffaMed Therapeutics obtains IND clearance for novel retinal biologic

By Rachel Arthur

AffaMed Therapeutics has announced that the US FDA has cleared its Investigational New Drug (IND) application for the clinical development of AM712 (ASKG712), a novel proprietary bispecific biologic molecule blocking both vascular endothelial growth factor...